Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1155820170120010011
Neurointervention
2017 Volume.12 No. 1 p.11 ~ p.19
Treatment of Intracranial Aneurysms with Flow Re-direction Endoluminal Device - A Single Centre Experience with Short-term Follow-up Results
Mahboobani Neeraj Ramesh

Chong Wing Ho
Lam Samuel Siu Kei
Siu Jimmy Chi Wai
Tan Chong Boon
Wong Yiu Chung
Abstract
Purpose: A flow diverter (FD) is an effective treatment option for intracranial aneurysms. The Flow Re-direction Endoluminal Device (FRED) is a relatively new flow diverter with a unique dual-layer design. We report our experience and short-term results with the FRED.

Materials and Methods: We did a retrospective review of all consecutive cases in which the FRED was used to treat intracranial aneurysms at a single institution from March 2014 till December 2015. Clinical parameters, aneurysm characteristics, technical results and short-term outcomes were reviewed.

Results: Eleven intracranial aneurysms were treated with the FRED in 11 patients. The technical device deployment success rate was 100%. Immediate reduction in intra-aneurysmal flow after deployment was noted in 10 cases. The aneurysm occlusion rate at 6 months was 75%. There was 1 complication of in-stent thrombosis immediately after deployment. There was no side branch occlusion, delayed aneurysm rupture, stroke, or intraparenchymal haemorrhage. There was no neurological deficit, morbidity, or mortality.

Conclusion: The FRED is a new FD. It has shown to be safe and effective in our series. The unique dual-layer design of the device renders it to have technical advantages over other FDs. The 6-month aneurysm occlusion rate and complication profile of FRED are similar to other FDs.
KEYWORD
Intracranial aneurysm, stents, flow diversion, flow diverters, FRED, Flow Re-direction Endoluminal Device
FullTexts / Linksout information
Listed journal information
KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø